HIGHLIGHTS
- who: Osteopontin level and colleagues from the This prospective study included , patients newly diagnosed with bca and distant metastasis who were recruited from the Oncology Center, Mansoura University, and the Department of Clinical Oncology and Nuclear Medicine, Mansoura University Hospital, EgyptThe patients recruited had been diagnosed with disseminated visceral metastasis (visceral crisis), with or without bone metastasis have published the paper: Osteopontin level and promoter polymorphism in patients with metastatic breast cancer, in the Journal: (JOURNAL)
- what: The authors aimed to illustrate the value of opn as a possible contributor in breast cancer ( bca). The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.